• 1
    Meenakshi S. S., Lendle S., van der Laan M., Kaskutas L., Ahern J. Cravings as a mediator and moderator of drinking outcomes in the COMBINE study. Addiction 2013; 108: 17371744.
  • 2
    Vassoler F. M., White S. L., Schmidt H. D., Sadri-Vakili G., Pierce R. C. Epigenetic inheritance of a cocaine-resistance phenotype. Nat Neurosci 2013; 16: 4247.
  • 3
    Flannery B. A., Poole S. A., Gallop R. J., Volpicelli J. R. Alcohol craving predicts drinking treatment: an analysis of three assessment instruments. J Stud Alcohol 2003; 64: 120126.
  • 4
    Anton R. F., O'Malley S. S., Ciraulo D. A., Cisler R. A., Couper D., Donovan D. M. et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006; 295: 20032017.
  • 5
    Anton R. F. Obsessive–compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale. Addiction 2000; 95: S211217.
  • 6
    Monterosso J. R., Flannery B. A., Pettinati H. M., Oslin D. W., Rukstalis M., O'Brien C. P. et al. Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict 2001; 10: 258268.
  • 7
    Monti P. M., Rohsenow D. J., Hutchison K. E., Swift R. M., Mueller T. I., Colby S. M. et al. Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 1999; 23: 13861394.
  • 8
    Roberts J. S., Anton R. F., Latham P. K., Moak D. H. Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale. Alcohol Clin Exp Res 1999; 23: 14841491.
  • 9
    O'Malley S. S., Krishnan-Sarin S., Farren C., Sinha R., Kreek M. J. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis. Psychopharmacology (Berl) 2002; 160: 1929.
  • 10
    Ooteman W., Koeter M. W. J., Verheul R., Schippers G. M., van den Brink W. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. Eur Neuropsychopharmacol 2007; 17: 558566.
  • 11
    Myrick H., Anton R. F., Li X., Henderson S., Randall P. K., Voronin K. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry 2008; 65: 466475.
  • 12
    Heinz A., Reimold M., Wrase J., Hermann D., Croissant B., Mundle G. et al. Correlation of stable elevations in striatal {micro}-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 2005; 62: 5764.
  • 13
    O'Malley S. S., Jaffe A. J., Chang G., Schottenfeld R. S., Meyer R. E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 1992; 49: 881887.
  • 14
    Anton R. F., Moak D. H., Waid L. R., Latham P. K., Malcolm R. J., Dias J. K. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 1999; 156: 17581764.
  • 15
    Anton R. F., Moak D. H., Latham P. K., Myrick D. L., Waid L. R. A double-blind comparison of naltrexone combined with CBT or MET in the treatment of alcohol dependence-within study and post-treatment results. Alcohol Clin Exp Res 2004; 28: 113A(P640).